Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02100566 · ClinicalTrials.gov registry record · NA
Behavioral Economics for Advance Care Options
A NA study, sponsored by Ascension Health.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT02100566: Completed NA study, sponsored by Ascension Health.
NCT02100566 is a NA study that has completed, run by Ascension Health. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02100566, a NA study, has completed, sponsored by Ascension Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
People with life-limiting illness often receive more aggressive healthcare than desired including costly procedures that provide little medical benefit. Advance Directives (AD) can reduce this effect but various factors limit their adoption. A randomized trial will target hospitalized patients with a serious, life limiting illness to test if the behavioral economics principles of endowment (possessing something) and focusing (featuring something important to patients) can motivate AD completion. Investigators will examine if offering patients an AD by default, in combination with framing the rationale for AD completion (emphasizing patient control or caregiver burden) improves AD completion and family conversation compared to a no-intervention group. The study hypothesis is to determine if rates of AD completion and family conversations will be highest among patients receiving the intervention focused on reduced caregiver burden; and if the two intervention groups will have higher rates of both than the control group. The investigators suspect that a small change in how patient information is framed (endowment and focusing used in tandem) will potentially leverage large increases in AD completion and that targeting HHC patients allows AD discussions early in the disease trajectory when they can participate in care decisions.
Primary Outcome
The number of advance directive documents completed within one month of enrollment.
Interventions
- BEHAVIORAL Counseling (Care giver burden focus)
- BEHAVIORAL Counseling (patient autonomy focus)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2014-04 |
| Est. Completion | 2019-10 |
| Phase | NA |
What the finished NCT02100566 record still lists
NCT02100566 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Counseling (Care giver burden focus) is the first listed.
NCT02100566 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02100566 about?
NCT02100566 is a clinical study titled "Behavioral Economics for Advance Care Options". People with life-limiting illness often receive more aggressive healthcare than desired including costly procedures that provide little medical benefit. Advance Directives (AD) can reduce this effect but various factors limit their adoption. A randomized trial will target hospitalized patients with...
What is the current status of trial NCT02100566?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2014-04. Estimated completion is 2019-10.
What interventions are being tested in trial NCT02100566?
The interventions under investigation include: Counseling (Care giver burden focus) (BEHAVIORAL), Counseling (patient autonomy focus) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02100566?
This trial is sponsored by Ascension Health, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02100566's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia